TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33751620

Group type: EXPERIMENTAL
Intervention: Marginal modeling approaches for the analysis of CRTs with truncated counts.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sample size formulas for CRTs with truncated counts.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Power calculation for a malaria control CRT.
Number of subjects: 0
Study: 32314621

Group type: EXPERIMENTAL
Intervention: Locking Plates (LPs)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Hook Plates (HPs)
Number of subjects: 64
Study: 33111587

Group type: EXPERIMENTAL
Intervention: Ketone (KET)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo (CON)
Number of subjects: 32
Study: 33829647

Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 371

Group type: COMPARATOR
Intervention: Enoxaparin followed by a vitamin K antagonist
Number of subjects: 371
Study: 36333174

Group type: EXPERIMENTAL
Intervention: Rater training
Number of subjects: 16
Study: 33753442

Group type: EXPERIMENTAL
Intervention: Multifactorial intervention (exercise and dietary advice)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Exercise only
Number of subjects: 0

Group type: COMPARATOR
Intervention: No interventions (Control group)
Number of subjects: 0
Study: 32028504

Group type: EXPERIMENTAL
Intervention: Labor Agentry Scale (continuous and categorical variable)
Number of subjects: 5185

Group type: EXPERIMENTAL
Intervention: Labor Agentry Scale score
Number of subjects: 5185

Group type: EXPERIMENTAL
Intervention: Labor Agentry Scale scores in the lowest two quintiles
Number of subjects: 5185
Study: 35380646

Group type: EXPERIMENTAL
Intervention: Implementation of the California Gun Violence Restraining Order (GVRO) law in San Diego County from 2016 to 2019
Number of subjects: 355
Study: 33247492

Group type: EXPERIMENTAL
Intervention: Ambulatory thyroidectomy
Number of subjects: 411
Study: 36745167

Group type: EXPERIMENTAL
Intervention: Ketofol
Number of subjects: 50

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Ketofol and Propofol
Number of subjects: 50
Study: 33528648

Group type: EXPERIMENTAL
Intervention: Orthokeratology lenses
Number of subjects: 36
Study: 32168362

Group type: EXPERIMENTAL
Intervention: Genetic variants acting in trans
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Genetic variants acting in cis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mendelian Randomization
Number of subjects: 0
Study: 35380053

Group type: EXPERIMENTAL
Intervention: Intravenous magnesium sulfate
Number of subjects: 268

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 268
Study: 33773988

Group type: EXPERIMENTAL
Intervention: Multicomponent nonpharmacologic intervention aimed at improving sleep-wake disruption (nighttime and daytime interventions)
Number of subjects: 646

Group type: EXPERIMENTAL
Intervention: Multicomponent nonpharmacologic intervention
Number of subjects: 646

Group type: COMPARATOR
Intervention: Preintervention period (baseline)
Number of subjects: 646
Study: 35962310

Group type: EXPERIMENTAL
Intervention: Calibrated PRO instruments
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-calibrated PRO instruments
Number of subjects: 0
Study: 33789444

Group type: EXPERIMENTAL
Intervention: Rotator cuff tear label
Number of subjects: 1308

Group type: EXPERIMENTAL
Intervention: Subacromial impingement syndrome label
Number of subjects: 1308

Group type: COMPARATOR
Intervention: Bursitis label
Number of subjects: 1308
Study: 33104028

Group type: EXPERIMENTAL
Intervention: Multi-Component Cognitive Stimulation Therapy (SADEM)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 67
Study: 35708700

Group type: EXPERIMENTAL
Intervention: Passive hot water immersion (PHWI)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: High intensity exercise (HIIE)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Moderate intensity exercise (continuous)
Number of subjects: 15
Study: 32505810

Group type: EXPERIMENTAL
Intervention: Daily oral xylitol wipes (7 g xylitol)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard oral hygiene regimen (SOC)
Number of subjects: 30
Study: 36093602

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 513

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 513
Study: 33653616

Group type: EXPERIMENTAL
Intervention: Music Therapy (MT)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control (no music)
Number of subjects: 90
Study: 32249915

Group type: EXPERIMENTAL
Intervention: PVI (no testing)
Number of subjects: 538

Group type: EXPERIMENTAL
Intervention: PVI + 30min waiting phase
Number of subjects: 538

Group type: EXPERIMENTAL
Intervention: PVI + ATP
Number of subjects: 538

Group type: EXPERIMENTAL
Intervention: PVI + 30min + ATP
Number of subjects: 538

Group type: COMPARATOR
Intervention: Patients with AF recurrence
Number of subjects: 538

Group type: COMPARATOR
Intervention: Patients without AF recurrence
Number of subjects: 538
Study: 36210436

Group type: EXPERIMENTAL
Intervention: ED GOAL intervention administered by trained nurses
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 120
Study: 34836170

Group type: EXPERIMENTAL
Intervention: Plant-based diet index
Number of subjects: 710

Group type: EXPERIMENTAL
Intervention: Nut intake
Number of subjects: 710

Group type: EXPERIMENTAL
Intervention: Fruit intake
Number of subjects: 710

Group type: EXPERIMENTAL
Intervention: Vegetable intake
Number of subjects: 710
Study: 35746524

Group type: EXPERIMENTAL
Intervention: Autogenous vaccine treatment (M. bovis, M. bovoculi, Mycoplasma bovoculi antigens)
Number of subjects: 1198

Group type: EXPERIMENTAL
Intervention: Commercial M. bovis vaccine treatment
Number of subjects: 1198

Group type: COMPARATOR
Intervention: Sham vaccine treatment (adjuvant only)
Number of subjects: 1198

Group type: EXPERIMENTAL
Intervention: Autogenous vaccine treatment
Number of subjects: 1198

Group type: COMPARATOR
Intervention: Sham vaccine treatment
Number of subjects: 1198
Study: 35010908

Group type: EXPERIMENTAL
Intervention: Very Low-Calorie Ketogenic Diet (VLCKD, 600-800 kcal/day)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Mediterranean Diet (MedDiet, estimated reduction of 500 kcal on the usual intake)
Number of subjects: 20
Study: 34263623

Group type: EXPERIMENTAL
Intervention: Intraoperative low-dose ketamine (0.2 mg/kg/h)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Normal saline infusion (control)
Number of subjects: 32
Study: 33008485

Group type: EXPERIMENTAL
Intervention: Fixator method
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Alternation method
Number of subjects: 95

Group type: COMPARATOR
Intervention: Adhesive/twill tape method
Number of subjects: 95
Study: 36005394

Group type: EXPERIMENTAL
Intervention: Early tensile loading (loaded group)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study: 34422157

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (1g in 10mls IV)
Number of subjects: 244

Group type: COMPARATOR
Intervention: Normal saline (10ml)
Number of subjects: 244
Study: 32034908

Group type: EXPERIMENTAL
Intervention: Looming vulnerability guided imagery induction
Number of subjects: 278

Group type: COMPARATOR
Intervention: Neutral guided imagery exercises (Control)
Number of subjects: 278
Study: 35862873

Group type: EXPERIMENTAL
Intervention: Goserelin (3.6 mg subcutaneously once every 28 days)
Number of subjects: 924

Group type: EXPERIMENTAL
Intervention: Tamoxifen (40 mg orally once daily)
Number of subjects: 924

Group type: EXPERIMENTAL
Intervention: Combined goserelin and tamoxifen
Number of subjects: 924

Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 924

Group type: EXPERIMENTAL
Intervention: Goserelin
Number of subjects: 924

Group type: EXPERIMENTAL
Intervention: Tamoxifen added to goserelin
Number of subjects: 924

Group type: COMPARATOR
Intervention: Control (no adjuvant endocrine therapy)
Number of subjects: 924
Study: 34822235

Group type: EXPERIMENTAL
Intervention: Spiritual intervention (5 sessions before chemotherapy)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 74
Study: 32744599

Group type: EXPERIMENTAL
Intervention: Individual pelvic floor muscle training (PFMT)
Number of subjects: 362

Group type: COMPARATOR
Intervention: Group-based pelvic floor muscle training (PFMT)
Number of subjects: 362

Group type: COMPARATOR
Intervention: Individual PFMT and Group-based PFMT
Number of subjects: 362
Study: 36446550

Group type: EXPERIMENTAL
Intervention: Double pigtail technique (DPT)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Lumen-apposing metal stents (LAMS)
Number of subjects: 42
Study: 34982448

Group type: EXPERIMENTAL
Intervention: Unaware of physical activity monitoring (Phase I for group A)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Aware of physical activity monitoring (Phase II for group A)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Unaware of physical activity monitoring (Phase II for group B)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Aware of physical activity monitoring (Phase I for group B)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Total physical activity (assessed by IPAQ)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Moderate physical activity (assessed by IPAQ)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Energy expenditure (assessed by IPAQ)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Sedentary behaviour (assessed by ActiGraph)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Average number of steps (assessed by ActiGraph)
Number of subjects: 35
Study: 32964833

Group type: EXPERIMENTAL
Intervention: Opioids only
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Combination of opioids and non-opioid CNSAM
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Non-opioid CNSAM only
Number of subjects: 300

Group type: COMPARATOR
Intervention: Reference group (no medication use)
Number of subjects: 300
Study: 35460726

Group type: EXPERIMENTAL
Intervention: Vebicorvir (VBR) 300 mg once daily + NrtI
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo (PBO) + NrtI
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Vebicorvir (VBR) + NrtI
Number of subjects: 73
Study: 32818353

Group type: EXPERIMENTAL
Intervention: Intracameral moxifloxacin (0.03 mL, 150 μg in 0.03 mL Vigamox solution)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Control group (no moxifloxacin)
Number of subjects: 93
Study: 35477618

Group type: EXPERIMENTAL
Intervention: Amphetamine Extended-Release Tablet (AMPH ER TAB) 5 mg starting dose, titrated to 20 mg
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 33872196

Group type: EXPERIMENTAL
Intervention: Hyaluronic acid (HA) gauze pad (0.05% HA)
Number of subjects: 168

Group type: COMPARATOR
Intervention: Neutral gauze pad (without HA)
Number of subjects: 168
Study: 33481840

Group type: EXPERIMENTAL
Intervention: TLC-NOSF dressings
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: TLC-NOSF dressings (initiated within two months)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Neutral dressings
Number of subjects: 0
Study: 32201975

Group type: EXPERIMENTAL
Intervention: Athletics health guidance (AHG)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Participatory action research (PAR)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: AHG areas of focus
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Best practice guidelines
Number of subjects: 0
Study: 35801274

Group type: EXPERIMENTAL
Intervention: Polymyxin B (PolyB 6000 IU/kg IV, 7 doses q12h)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Polymyxin B/gentamicin (PolyB 6000 IU/kg IV, q12h 7 doses; gentamicin 10 mg/kg IV q24h 4 doses)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Polymyxin B/gentamicin
Number of subjects: 6
Study: 33813779

Group type: EXPERIMENTAL
Intervention: Machine learning algorithm using convolutional neural networks (CNN) for glomerulus detection
Number of subjects: 71
Study: 35417771

Group type: EXPERIMENTAL
Intervention: Brief Intervention‐Medication Therapy Management (BI‐MTM)
Number of subjects: 350

Group type: COMPARATOR
Intervention: Standard Medication Counseling (SMC)
Number of subjects: 350
Study: 32461125

Group type: EXPERIMENTAL
Intervention: Intradiscal injection of glucocorticoids (50mg prednisolone acetate), n=24
Number of subjects: 50

Group type: COMPARATOR
Intervention: Intradiscal injection of lidocaine (40mg), n=26
Number of subjects: 50
Study: 32505660

Group type: EXPERIMENTAL
Intervention: Active theta tACS stimulation (1 mA peak-to-peak intensity for approximately 20 min)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Sham stimulation (30 s duration)
Number of subjects: 26
Study: 35167913

Group type: COMPARATOR
Intervention: Tension band wire technique (TBW)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Tension band tape technique (TBT)
Number of subjects: 20
Study: 34196004

Group type: EXPERIMENTAL
Intervention: YouTube video content analysis
Number of subjects: 136
Study: 32594139

Group type: EXPERIMENTAL
Intervention: Active transcranial direct current stimulation (tDCS) for five days
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham transcranial direct current stimulation (tDCS)
Number of subjects: 30
Study: 34025075

Group type: EXPERIMENTAL
Intervention: Active treatment group (30-g or 60-g superdonor faeces)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Placebo group (own faeces)
Number of subjects: 164
Study: 33791095

Group type: EXPERIMENTAL
Intervention: Amoxicillin treatment (duration not specified)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Children with chest-indrawing pneumonia and comorbidities (HIV infection or exposure, malaria, moderate or severe acute malnutrition)
Number of subjects: 0
Study: 32844549

Group type: EXPERIMENTAL
Intervention: Computable phenotype algorithm for resistant hypertension (RHTN)
Number of subjects: 156730

Group type: EXPERIMENTAL
Intervention: Computable phenotype algorithm for stable controlled hypertension (HTN)
Number of subjects: 156730

Group type: EXPERIMENTAL
Intervention: Interrater reliability (IRR) analysis
Number of subjects: 156730
Study: 34981245

Group type: EXPERIMENTAL
Intervention: Noble metal alloy (NMA) coated endotracheal tubes (ETT)
Number of subjects: 323

Group type: COMPARATOR
Intervention: Control group (non-coated endotracheal tubes)
Number of subjects: 323
Study: 32655260

Group type: EXPERIMENTAL
Intervention: Extended lymphadenectomy including para-aortic lymph nodes dissection
Number of subjects: 0

Group type: COMPARATOR
Intervention: Radical resection combined with postoperative adjuvant chemotherapy
Number of subjects: 0
Study: 36137731

Group type: EXPERIMENTAL
Intervention: Early ACL reconstruction (n=85)
Number of subjects: 167

Group type: COMPARATOR
Intervention: Rehabilitation therapy plus optional delayed ACL reconstruction (n=82)
Number of subjects: 167

Group type: COMPARATOR
Intervention: Patients who received no ACL reconstruction (n=41)
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Patients who received early ACL reconstruction (n=82) and patients that received delayed ACL reconstruction (n=41)
Number of subjects: 167
Study: 34286901

Group type: EXPERIMENTAL
Intervention: Group U + CHX (universal adhesive with chlorhexidine pretreatment)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Group C (no IDS)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Group ER + CHX (etch & rinse adhesive with chlorhexidine pretreatment)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Group ER (etch & rinse adhesive without chlorhexidine pretreatment)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Group U (universal adhesive without chlorhexidine pretreatment)
Number of subjects: 75
Study: 35021915

Group type: EXPERIMENTAL
Intervention: Cold-water immersion (20-30°C for 20 minutes/day for 4 weeks)
Number of subjects: 76
Study: 33225615

Group type: EXPERIMENTAL
Intervention: Oxytocin (24-IU single-dose intranasal)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 33731168

Group type: EXPERIMENTAL
Intervention: Bone turnover marker (BTM) monitoring with alendronate, calcitriol, and calcium; medication duration was prolonged based on BTM results.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group received oral medication (alendronate, calcitriol, and calcium) for a uniform duration of 3 months.
Number of subjects: 0
Study: 32220693

Group type: EXPERIMENTAL
Intervention: Asymptomatic bacteriuria positive group (ASB positive)
Number of subjects: 1610

Group type: COMPARATOR
Intervention: Asymptomatic bacteriuria negative group (ASB negative)
Number of subjects: 1610

Group type: EXPERIMENTAL
Intervention: Women with ASB but not a short CL
Number of subjects: 1610

Group type: EXPERIMENTAL
Intervention: Women without ASB and no short CL
Number of subjects: 1610
Study: 33479040

Group type: EXPERIMENTAL
Intervention: Enhanced care package delivered by non-physicians
Number of subjects: 120

Group type: COMPARATOR
Intervention: Standard care from outpatient physicians
Number of subjects: 120
Study: 32934804

Group type: EXPERIMENTAL
Intervention: 30 mg nefopam before surgical incision and normal saline before the end of surgery (Nefopam-Placebo)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Normal saline before surgical incision and 30 mg of nefopam before the end of surgery (Placebo-Nefopam)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: 30 mg nefopam in both timings (Nefopam-Nefopam)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Normal saline before surgical incision and before the end of surgery (Placebo-Placebo)
Number of subjects: 96
Study: 33502244

Group type: EXPERIMENTAL
Intervention: Emotional loneliness
Number of subjects: 3821

Group type: EXPERIMENTAL
Intervention: Social loneliness
Number of subjects: 3821

Group type: EXPERIMENTAL
Intervention: Emotional social support and quality of life
Number of subjects: 3821

Group type: EXPERIMENTAL
Intervention: Social capital in the neighbourhood, companionship, and instrumental support
Number of subjects: 3821

Group type: EXPERIMENTAL
Intervention: Demographic variables
Number of subjects: 3821
Study: 34532085

Group type: EXPERIMENTAL
Intervention: Telerehabilitation
Number of subjects: 86
Study: 35655244

Group type: EXPERIMENTAL
Intervention: Community pharmacist intervention (active collection of information from family physicians and care managers)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (normal duties of pharmacists)
Number of subjects: 18
Study: 33310802

Group type: EXPERIMENTAL
Intervention: Telemedicine programme (electroanalgesia and McKenzie method exercises)
Number of subjects: 540

Group type: COMPARATOR
Intervention: Face-to-face programme (electroanalgesia and McKenzie method exercises)
Number of subjects: 540
Study: 36066959

Group type: EXPERIMENTAL
Intervention: AI interpretation (automated machine translation) during psychiatric interviews
Number of subjects: 6

Group type: COMPARATOR
Intervention: Human interpretation (Spanish-speaking human interpreter) during psychiatric interviews
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: AI interpretation via videoconferencing
Number of subjects: 6
Study: 34462252

Group type: EXPERIMENTAL
Intervention: AVAPS
Number of subjects: 80

Group type: COMPARATOR
Intervention: S/T
Number of subjects: 80
Study: 35108492

Group type: EXPERIMENTAL
Intervention: Hypnosis (3 hypnotherapy sessions, once a month)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control (health education: diet + exercise + behavioral recommendations)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Self-hypnosis (practiced frequently by participants in IG)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Both groups (IG and CG)
Number of subjects: 104
Study: 33388929

Group type: EXPERIMENTAL
Intervention: Combined aerobic-strength training program
Number of subjects: 32

Group type: COMPARATOR
Intervention: Flexibility training (stretching control group)
Number of subjects: 32
Study: 33571293

Group type: EXPERIMENTAL
Intervention: Cannabis (0.5 g dried cannabis flowers with 80 mg THC)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 32468687

Group type: EXPERIMENTAL
Intervention: Nutrition education intervention (four nutrition classes and monthly home visits by cadres)
Number of subjects: 266

Group type: COMPARATOR
Intervention: Control group (standard monthly health care at the health post)
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Nutrition education intervention
Number of subjects: 266
Study: 35644694

Group type: EXPERIMENTAL
Intervention: Ubiquinol and D-ribose
Number of subjects: 216

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 216
Study: 32390120

Group type: EXPERIMENTAL
Intervention: OWHTO and arthroscopic all‐inside meniscal repair (Group A, n=30)
Number of subjects: 90

Group type: COMPARATOR
Intervention: OWHTO only (Group B, n=34)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Arthroscopic partial meniscectomy (Group C, n=26)
Number of subjects: 90
Study: 33021355

Group type: EXPERIMENTAL
Intervention: sacubitril/valsartan
Number of subjects: 0

Group type: COMPARATOR
Intervention: valsartan
Number of subjects: 0
Study: 34329337

Group type: EXPERIMENTAL
Intervention: HD-MAP with 15 μg HA
Number of subjects: 10

Group type: COMPARATOR
Intervention: Uncoated placebo HD-MAPs
Number of subjects: 10
Study: 32304710

Group type: EXPERIMENTAL
Intervention: Vancomycin group (pre-soaked in 5mg/ml vancomycin for 10 minutes)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (pre-soaked in physiological serum for 10 minutes)
Number of subjects: 30
Study: 36096387

Group type: EXPERIMENTAL
Intervention: Teriparatide
Number of subjects: 77

Group type: COMPARATOR
Intervention: Zoledronate
Number of subjects: 77
Study: 32019483

Group type: EXPERIMENTAL
Intervention: Suicide-related news articles
Number of subjects: 420

Group type: COMPARATOR
Intervention: Neutral news articles
Number of subjects: 420
Study: 35189939

Group type: EXPERIMENTAL
Intervention: Hybrid endoscopic submucosal dissection (H‐ESD)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Conventional endoscopic submucosal dissection (C‐ESD)
Number of subjects: 82
Study: 34321092

Group type: EXPERIMENTAL
Intervention: Walking prescription of 150 min/week during pre-surgical waiting time
Number of subjects: 368

Group type: COMPARATOR
Intervention: Conventional care
Number of subjects: 368